Merit Medical Systems, Inc. (MMSI): Price and Financial Metrics

Merit Medical Systems, Inc. (MMSI)

Today's Latest Price: $46.56 USD

1.29 (2.85%)

Updated Aug 13 5:20pm

Add MMSI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 133 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

MMSI Stock Summary

  • MMSI's went public 28.48 years ago, making it older than 81.6% of listed US stocks we're tracking.
  • Price to trailing twelve month operating cash flow for MMSI is currently 21.78, higher than 79.98% of US stocks with positive operating cash flow.
  • Over the past twelve months, MMSI has reported earnings growth of -144.1%, putting it ahead of just 13.45% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Merit Medical Systems Inc, a group of peers worth examining would be MSA, XRX, XYL, SYK, and HRC.
  • MMSI's SEC filings can be seen here. And to visit Merit Medical Systems Inc's official web site, go to
MMSI Daily Price Range
MMSI 52-Week Price Range

MMSI Stock Price Chart Technical Analysis Charts

MMSI Price/Volume Stats

Current price $46.56 52-week high $47.99
Prev. close $45.27 52-week low $19.50
Day low $44.99 Volume 281,961
Day high $46.64 Avg. volume 537,426
50-day MA $43.92 Dividend yield N/A
200-day MA $36.85 Market Cap 2.58B

Merit Medical Systems, Inc. (MMSI) Company Bio

Merit Medical Systems is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. The company was founded in 1987 and is based in South Jordan, Utah.

MMSI Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$46.56$16.03 -64%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Merit Medical Systems Inc. To summarize, we found that Merit Medical Systems Inc ranked in the 24th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 63.5%. In terms of the factors that were most noteworthy in this DCF analysis for MMSI, they are:

  • Merit Medical Systems Inc's effective tax rate, as measured by taxes paid relative to net income, is at 24 -- greater than 86.48% of US stocks with positive free cash flow.
  • Merit Medical Systems Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -2.06. This coverage rate is greater than that of only 16.23% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • The weighted average cost of capital for the company is 10. This value is greater than 82.68% stocks in the Healthcare sector that generate free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MMSI, try ENTA, HSIC, SNN, HAPP, and HOLX.

MMSI Latest News Stream

Event/Time News Detail
Loading, please wait...

MMSI Latest Social Stream

Loading social stream, please wait...

View Full MMSI Social Stream

Latest MMSI News From Around the Web

Below are the latest news stories about Merit Medical Systems Inc that investors may wish to consider to help them evaluate MMSI as an investment opportunity.

Merit Medical (MMSI) Beats Q2 Earnings and Revenue Estimates

Merit Medical (MMSI) reported a drop in revenues at every key operating segment in Q2.

Yahoo | July 30, 2020

Merit Medical Systems Inc (MMSI) Q2 2020 Earnings Call Transcript

MMSI earnings call for the period ending June 30, 2020.

Yahoo | July 30, 2020

Merit Medical Systems EPS beats by $0.24, beats on revenue

Merit Medical Systems (MMSI): Q2 Non-GAAP EPS of $0.31 beats by $0.24; GAAP EPS of -$0.34 misses by $0.15.Revenue of $218.37M (-14.5% Y/Y) beats by $25.7M.Press Release...

Seeking Alpha | July 29, 2020

Merit Medical Reports Results for Quarter Ended June 30, 2020

* Q2 2020 worldwide revenue of $218.4 million, down (14.5)% as reported compared to Q2 2019 * Q2 2020 core revenue on a constant currency basis* down (13.6)% compared to Q2 2019 * Q2 2020 GAAP loss per share was $(0.34), compared to GAAP EPS of $0.12 in Q2 2019 * Q2 2020 non-GAAP EPS* was $0.31, compared to $0.42 in Q2 2019 * Q2 2020 free cash flow* was $32 million, and $47 million YTD* Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin, non-GAAP gross margin and free cash flow are non-GAAP financial measures. A reconciliation of these and other non-GAAP financial measures used in this release to their most directly comparable GAAP financial measures is included under the heading “Non-GAAP Financial Measures” below.SOUTH JORDAN, U...

Yahoo | July 29, 2020

Earnings Preview: Merit Medical (MMSI) Q2 Earnings Expected to Decline

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 22, 2020

Read More 'MMSI' Stories Here

MMSI Price Returns

1-mo 7.55%
3-mo 17.52%
6-mo 13.81%
1-year 27.91%
3-year 15.25%
5-year 88.58%
YTD 49.14%
2019 -44.06%
2018 29.19%
2017 63.02%
2016 42.55%
2015 7.27%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9874 seconds.